RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury.
Level 5 - mechanism / opinion, no new human data
Preclinical bench and cellular mechanism study with no human data.
PubMed 31484925 · doi:10.1038/s41467-019-11870-x
What was done
The authors investigated the role of RNA-binding motif protein 3 (RBM3) in adult neurogenesis and cell survival after hypoxic-ischemic (HI) brain injury. They evaluated neural stem/progenitor cell (NSPC) proliferation, differentiation, and apoptosis in the subventricular zone (SVZ) and the subgranular zone (SGZ), and examined downstream signaling involving IGF2 mRNA binding protein 2 (IMP2) and insulin-like growth factor 2 (IGF2).
What was found
The abstract reports no numerical values, effect sizes, or statistical test results. Qualitatively, RBM3 promoted neuronal differentiation and inhibited HI-induced apoptosis in both the SVZ and SGZ. RBM3 stimulated NSPC proliferation after HI injury solely in the SGZ. Mechanistically, RBM3 interacted with IMP2, increased IMP2 expression, and stimulated IGF2 release in SGZ-derived NSPCs but not in SVZ-derived NSPCs.
Why it matters
Therapeutic hypothermia provides neuroprotection following hypoxic-ischemic injury but carries significant side effects in adults. Identifying the RBM3-IMP2-IGF2 signaling pathway reveals a molecular target that could potentially stimulate niche-specific neural repair without systemic cooling.
Limits
The abstract provides no sample size, animal or cell model details, quantitative metrics, or variance estimates. Findings are restricted to preclinical laboratory models and lack validation in human clinical populations or functional neurological outcomes.
Cited by
- context Cold plunging stimulates neurogenesis and the growth of new brain cells.